GaBI Educational Forum aims to enhance the knowledge on and understanding of key issues relating to regulatory approval and quality assessment of and good manufacturing practice for biologicals/biosimilars, as well as associated topics such as good manufacturing practices, clinical trials, interchangeability, pharmacovigilance, registries in biologicals/biosimilars.
The events are organized in collaboration with either the regulatory authority or reputable academic institution for regulators, academics, medical practitioners/specialists and health system stakeholders from different countries and regions.
To further share information and expertise, all speakers’ presentations are available online, and the meeting report of each event is published in GaBI Journal to document the discussions and learning.
By end of 2021, the GaBI Educational Forum has provided a productive and open learning environment in 12 countries over three continents to 897 key participants from 38 countries on focus key topics of biologicals/biosimilars, offering a discussion forum for national, regional and international colleagues to explore ways to communicate the biosimilars concept to physicians and patients.
Virtual educational workshops/scientific meetings/conferences for clinicians/physicians, academics, regulators and other stakeholders on nomenclature of biologicals, regulatory standards on biosimilars, non-medical switching, success factors of biosimilars uptake are being delivered in 2022.
Upcoming webinars on 1) ophthalmic biosimilars; 2) regulatory considerations, pharmacovigilance, switching/interchangeability for healthcare professionals in Argentina, plus more are planned for 2022. Contact us for more information.
View the latest webinars GaBI organized:
NON-MEDICAL SWITCHING OF BIOLOGICALS/BIOSIMILARS: CANADA, EUROPE AND THE US, 20 July 2022
KEY FACTORS FOR SUCCESSFUL UPTAKE OF BIOSIMILARS: EUROPE AND THE US, 29 June 2022
GaBI educational workshops aim to provide training opportunities in focus topics identified by members of the journal editorial boards, reflecting the current educational needs of the target audience. Workshop topics in areas such as bioequivalence methodology, biopharmaceutical production, quality evaluation in general and generic drug evaluation in particular health economics, drug substitution issues and risk management programmes. GaBI educational workshops are delivered by recognized experts and are open to an international audience to promote common understanding and practical approach on the issues discussed in view of the GaBI mission: building trust in cost-effective treatments.
By end of 2021, GaBI has delivered 12 educational workshops in Belgium, Colombia, Indonesia, Malaysia, Mexico, Thailand, Turkey, Vietnam and UAE.
If you have any suggestions on generics and biosimilars scientific developments with appealing topics for an educational workshop, please contact us for further discussion.
View the latest educational workshops GaBI organized:
2nd ASEAN Educational Workshop on GMP FOR BIOLOGICALS/BIOSIMILARS 2019
2nd Turkish Interactive Workshop on REGULATORY ASSESSMENT OF BIOSIMILARS 2019
2nd ASEAN Educational Workshop on REGULATORY CONSIDERATIONS FOR BIOSIMILARS 2019
3rd Colombian Educational Workshop on REGULATORY ASSESSMENT OF BIOSIMILARS 2019
1st ASEAN Overview Workshop on GMP for BIOLOGICALS/BIOSIMILARS 2018
First ASEAN Educational Workshop on Regulation and Approval of Biosimilars/Similar Biotherapeutic Products 2017
First INVIMA Educational Workshop on Assessment of Similar Biotherapeutic Products 2016
First Turkish Interactive Workshop on Regulation and Approval of Similar Biotherapeutic Products/Biosimilars 2016
First MENA Educational Workshop on Similar Biotherapeutic Products/Biosimilars 2015
First Latin American Educational Workshop on Similar Biotherapeutic Products 2015
First Asia-Pacific Educational Workshop Non-Biological Complex Drugs 2013
Non-Biological Complex Drugs Educational Workshop 2014
GaBI organizes and supports the organization of scientific conferences that advocate the importance of advancing generic and biosimilar medicines as the high quality, affordable, accessible and sustainable healthcare alternative. Authoritative figures and leaders in the scientific field of generics and biosimilars will be invited as guest speakers to share their views, or to communicate outcomes of original research, to an international audience.
By end of 2021, GaBI has organized seven scientific meetings in Belgium, Cambodia, Colombia, Saudi Arabia, Spain, UAE, and the UK.
View the latest scientific conferences/meetings GaBI organized:
2nd MENA Stakeholder Meeting on Regulatory Approval, Clinical Settings, Interchangeability and Pharmacovigilance of Biosimilars 2018
First GCC Stakeholder Meeting on Approval Process, Interchangeability/Substitution and Safety of Biosimilars 2017
Second Colombian Scientific Meeting on Quality Assessment of Biosimilars/Similar Biotherapeutic Products 2017
ROUNDTABLE ON REGISTRIES: Practical Considerations for Registries – making them work 2017
ROUNDTABLE ON BIOSIMILARS – Pharmacovigilance, Traceability, Immunogenicity 2016
Second Asia-Pacific Roundtable on Non-Biological Complex Drugs 2016
ROUNDTABLE ON BIOSIMILARS with participation by European Regulators and Medical Societies 2016